Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong New Era Pharmaceutical
Weihai City, Shandong, Chinashandong-new-era-pharmaceutical-ltd.en.drugdu.com ↗
- Ownership
- Private
- Employees
- ~250
- Development stage
- Other
01
Overview
Shandong New Era Pharmaceutical is an active Chinese manufacturer specializing in pharmaceutical intermediates, fluorosilicon fine chemicals, new materials, green polymer materials, and high-end chemical equipment. The company operates at commercial scale with global export capabilities. No clinical trial results are reported as it does not develop finished drugs but supplies key ingredients for further drug development or manufacturing.
- Modalities
- Small molecule
- Industry
- Chemicals & Materials
Beyond the preview
Go deeper on Shandong New Era Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shandong New Era Pharmaceutical.